Showing 11,441 - 11,460 results of 102,778 for search '(( 2 step decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.62s Refine Results
  1. 11441

    Table2_MircroRNA Let-7a-5p in Airway Smooth Muscle Cells is Most Responsive to High Stretch in Association With Cell Mechanics Modulation.DOCX by Kang Wen (7186409)

    Published 2022
    “…Direct binding between let-7a-5p and ItgαV was also verified in classical model cell line by using dual-luciferase assays.…”
  2. 11442

    Video4_MircroRNA Let-7a-5p in Airway Smooth Muscle Cells is Most Responsive to High Stretch in Association With Cell Mechanics Modulation.AVI by Kang Wen (7186409)

    Published 2022
    “…Direct binding between let-7a-5p and ItgαV was also verified in classical model cell line by using dual-luciferase assays.…”
  3. 11443

    Video1_MircroRNA Let-7a-5p in Airway Smooth Muscle Cells is Most Responsive to High Stretch in Association With Cell Mechanics Modulation.AVI by Kang Wen (7186409)

    Published 2022
    “…Direct binding between let-7a-5p and ItgαV was also verified in classical model cell line by using dual-luciferase assays.…”
  4. 11444

    Video2_MircroRNA Let-7a-5p in Airway Smooth Muscle Cells is Most Responsive to High Stretch in Association With Cell Mechanics Modulation.AVI by Kang Wen (7186409)

    Published 2022
    “…Direct binding between let-7a-5p and ItgαV was also verified in classical model cell line by using dual-luciferase assays.…”
  5. 11445
  6. 11446

    DataSheet_1_MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer.docx by Blanca I. Quiñones-Díaz (9863657)

    Published 2020
    “…Notably, miR-18a-5p (miR-18a), a member of the oncogenic associated miR-17-92 cluster, was decreased in cisplatin-resistant as compared with cisplatin-sensitive cells. …”
  7. 11447

    Thermorheological characteristics and extrudability aptitude of a new amylose-free cassava starch by Adriana Pulido Diaz (10448430)

    Published 2023
    “…Nowadays, the development of new cultivars with specific properties has become a major research area. In this research, amylose-free cassava starch (WXCS) extracted from clone AM206-5 was evaluated with respect to its physicochemical, morphological, and thermorheological properties. …”
  8. 11448

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  9. 11449

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  10. 11450
  11. 11451

    Primers used in this study. by Yongle Zhang (11355546)

    Published 2025
    “…Consistently, <i>N. benthamiana</i> plants infected with mutated CTV<sup>mAIM1</sup> and CTV<sup>mAIM5</sup> showed milder symptoms and decreased viral accumulation. …”
  12. 11452

    Ubiquitin-Specific Peptidase 5, a Target Molecule of Vialinin A, Is a Key Molecule of TNF-α Production in RBL-2H3 Cells by Yasukiyo Yoshioka (492618)

    Published 2013
    “…Here we report production of TNF-α is decreased in USP5 siRNA-knockdown RBL-2H3 cells, compared with control cells. …”
  13. 11453

    Datasets analyzed. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    “…In HER2-positive breast cancer patients, MAF1 expression significantly increases and correlates with five years of relapse-free survival in response to trastuzumab treatment, suggesting MAF1 is a predictive biomarker in breast cancer. …”
  14. 11454
  15. 11455

    New Horizons in Micro/Nanoplastic-Induced Oxidative Stress: Overlooked Free Radical Contributions and Microbial Metabolic Dysregulations in Anaerobic Digestion by Xingxing Zhang (173950)

    Published 2024
    “…The formation of <sup>•</sup>OH enhanced ROS production by 86.2–100.9%, resulting in decreased cellular viability and methane production (by 37.5–50.5%) at 100 mg/g TS PP-MPs/NPs. …”
  16. 11456
  17. 11457
  18. 11458

    (A) Activation maps contrasting the control group with the 5-HT- group showing a significant effect for aversive prediction error signals (PE) in the orbitofrontal cortex (left) an... by Catherine Hindi Attar (303972)

    Published 2013
    “…(B) Peak voxel parameter estimates show decreased aversive PE signals for the 5-HT depleted group (TRP-) compared to the control group (TRP+). …”
  19. 11459

    Ethogram describing all outcome measures. by Sara Hintze (3216885)

    Published 2024
    “…Apathetic animals are hypothesised to show a decreased interest in stimuli of all valences, whereas depressed animals are thought to be less interested in positive stimuli only, due to anhedonia, a key symptom of depression. …”
  20. 11460

    A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients by Takanori Watanabe (2159686)

    Published 2019
    “…The mean period of wig use was 12.5 months. However, a few patients were still using wigs 5 years after completing chemotherapy.…”